AI Verdict
SYK has stronger fundamentals based on our AI analysis.
CVS vs SYK Fundamental Comparison
| Metric | CVS | SYK |
|---|---|---|
| Revenue | $402.1B | $25.1B |
| Net Income | $1.8B | $3.2B |
| Net Margin | 0.4% | 12.9% |
| ROE | 2.4% | 14.5% |
| ROA | 0.7% | 6.8% |
| Current Ratio | 0.84x | 1.89x |
| Debt/Equity | 0.85x | 0.66x |
| EPS | $1.39 | $8.40 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
CVS vs SYK: Frequently Asked Questions
Is CVS or SYK a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), SYK has stronger fundamentals. CVS is rated HOLD (70% confidence) while SYK is rated BUY (86% confidence). This is not investment advice.
How does CVS compare to SYK fundamentally?
CVS HEALTH Corp has ROE of 2.4% vs STRYKER CORP's 14.5%. Net margins are 0.4% vs 12.9% respectively.
Which stock pays higher dividends, CVS or SYK?
CVS has a dividend yield of N/A or no dividend while SYK has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in CVS or SYK for long term?
For long-term investing, consider that CVS has HOLD rating with 70% confidence, while SYK has BUY rating with 86% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about CVS vs SYK?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For CVS vs SYK, the AI consensus favors SYK based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.